{
    "Title": "Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh",
    "URL": "https://doi.org/10.1371/journal.pntd.0005635",
    "Published": "May 30, 2017",
    "Subject_Areas": [
        "Adverse events",
        "Bangladesh",
        "Drug therapy",
        "Leishmaniasis",
        "India",
        "Vomiting",
        "Phase III clinical investigation",
        "Drug research and development"
    ],
    "Authors": {
        "Ridwanur Rahman": [
            "Shaheed Suhrawardy Medical College (ShSMC), University of Dhaka, Dhaka, Bangladesh"
        ],
        "Vishal Goyal": [
            "Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"
        ],
        "Rashidul Haque": [
            "International Centre for Diarrhoeal Disease Research (ICDDR,B), Dhaka, Bangladesh"
        ],
        "Kazi Jamil": [
            "Kuwait institute for Scientific Research, Environment and Life Sciences Research centre, Food and Nutrition Program formerly ICDDR,B, Dhaka, Bangladesh"
        ],
        "Abul Faiz": [
            "Dev Care Foundation, Dhaka, Bangladesh and Retired Ministry of Health, Government official Dhaka, Bangladesh"
        ],
        "Rasheda Samad": [
            "Chittagong Medical College, Chittagong, Bangladesh"
        ],
        "Sally Ellis": [
            "Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"
        ],
        "Manica Balasegaram": [
            "Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"
        ],
        "Margriet den Boer": [
            "Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"
        ],
        "Suman Rijal": [
            "Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"
        ],
        "Nathalie Strub-Wourgaft": [
            "Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"
        ],
        "Fabiana Alves": [
            "Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"
        ],
        "Jorge Alvar": [
            "Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"
        ],
        "Bhawna Sharma": [
            "Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland"
        ]
    }
}